Asia-Pacific Vaccine Administration Devices Market, By Product (Syringes, Auto Injectors, Jet Injectors, Micro Needles, Inhalation/Pulmonary Delivery, Microinjection System, Pen Injector Devices, Biodegradable Implants, Electroporation-Based Needle Free Injection Systems, Buccal /Sublingual Vaccine Delivery Systems, Auto-Injector Trainer Devices and Others Devices), Route of Administration (Intramuscular, Subcutaneous, Intradermal), Type (Marketed Vaccines and Clinical-Stage Vaccines (Electroporation)), Brand (BD Accuspray Nasal Spray System, BD Hypak for Vaccines Glass Pre-Fillable Syringe System, BD Uniject Auto-Disable Pre-Fillable Injection System, Gx InnoSafe, Gx RTF ClearJect, Plajex, Others), Dosage (Fixed and Variable), Vaccine Type (Bivalent Oral PolioVaccine, B.C.G. Vaccine, Tetanus-Diphtheria Vaccine, DTP-HEPB-HIB Vaccine, Influenza Vaccine, Pneumococcal Conjugate Vaccine, Measles Vaccine, Others), Modality (Automatic Vaccine Administration Device and Manual Vaccine Administration Device), Usability (Disposable and Reusable), End User (Hospitals, Community Centers, Homecare Setting, Research and Academic Institutes, Ambulatory Surgical Center, Others), Distribution Channel (Direct Tender, Retail Sales) – Industry Trends and Forecast to 2030.
Asia-Pacific Vaccine Administration Devices Market Analysis and Size
The vaccine administration devices market is increasing due to the vaccine administration devices awareness of immunization by WHO and many governments and NGOs globally. Novel and technologically advanced syringes, such as auto-disposable and prefilled syringes, are gaining much popularity. In partnership with governments worldwide, several biotech and pharmaceutical companies are working towards the strategy for supply chain challenges in vaccine delivery and developing effective vaccinations.
Data Bridge Market Research analyses a growth rate in the vaccine administration devices market in the forecast period 2023-2030. The expected CAGR of the vaccine administration devices market tends to be around 6.90% in the mentioned forecast period. The market was valued at USD 585.92 million in 2022 and will grow to USD 999.22 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Asia-Pacific Vaccine Administration Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Syringes, Auto Injectors, Jet Injectors, Micro Needles, Inhalation/Pulmonary Delivery, Microinjection System, Pen Injector Devices, Biodegradable Implants, Electroporation-Based Needle Free Injection Systems, Buccal /Sublingual Vaccine Delivery Systems, Auto-Injector Trainer Devices and Others Devices), Route of Administration (Intramuscular, Subcutaneous, Intradermal), Type (Marketed Vaccines and Clinical-Stage Vaccines (Electroporation)), Brand (BD Accuspray Nasal Spray System, BD Hypak for Vaccines Glass Pre-Fillable Syringe System, BD Uniject Auto-Disable Pre-Fillable Injection System, Gx InnoSafe, Gx RTF ClearJect, Plajex, Others), Dosage (Fixed and Variable), Vaccine Type (Bivalent Oral PolioVaccine, B.C.G. Vaccine, Tetanus-Diphtheria Vaccine, DTP-HEPB-HIB Vaccine, Influenza Vaccine, Pneumococcal Conjugate Vaccine, Measles Vaccine, Others), Modality (Automatic Vaccine Administration Device and Manual Vaccine Administration Device), Usability (Disposable and Reusable), End User (Hospitals, Community Centers, Homecare Setting, Research and Academic Institutes, Ambulatory Surgical Center, Others), Distribution Channel (Direct Tender, Retail Sales)
|
|
Countries Covered
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
|
|
Market Players Covered
|
BD. (US), INOVIO Pharmaceuticals (US), Vaxxas (US), Gerresheimer AG (Germany), Corium Inc. (US), Enesi (US), Micropoint Technologies (Singapore), SCHOTT AG (Germany), 3M (US), Mystic Pharmaceuticals (US), NanoPass Rev (US), Terumo Asia-Pacific NV (Belgium), D'Antonio Consultants International, Inc. (US), West Pharmaceutical Services, Inc. (US)., Mylan NV (US), Medical International Technologies Inc. (Canada), Antares Pharma (US.)
|
|
Market Opportunities
|
|
Market Definition
Vaccines are a set of biological preparations that protect humans from viruses and bacteria-related infections. Some vaccine kinds are live/attenuated vaccines, inactivated/killed vaccines, toxoid vaccines, and conjugate vaccines. Using a syringe or needle, vaccines are administered intramuscularly or subcutaneously. Needle-free technologies are unique vaccine administration technologies as they are highly effective in mass immunization programs. They reduce the risk of needle stick injuries and the consequences of many needles use.
Asia-Pacific Vaccine Administration Devices Market Dynamics
Drivers
- Increasing Healthcare Expenditure from Different Organizations
Immunization coverage is increasing with financial support from international organizations such as Bill & Melinda Gates Foundation, GAVI Alliance, and Path. More vaccines, including those for life-threatening diseases, are increasingly accessible to the population. In underdeveloped and developing nations, innovative funding mechanisms are applied to increase vaccination coverage and provide new vaccines. Furthermore, Global Alliance for Vaccines and Immunizations (GAVI) extended its support in June 2017. This will make the vaccine available to millions of children through the routine immunization program to eliminate polio. Thus, this factor increases the growth of the market.
- Rising Adoption of Needleless Delivery System
The needleless delivery system is a major factor leading to the growth of the vaccine administration device market. These systems can potentially decrease the dose of vaccine antigens and enhance the immunogenicity of the vaccine. Rapid technological advances such as micro-needling and electroporation are anticipated to increase the market's growth. The increased use of microneedles is because of the patient's demand for painless self-administration. Vaccines administered to the dermis through microneedles act faster than intramuscular injections. Thus, this factor help in increasing the market growth.
Opportunities
- Growing Demand of Intramuscular Vaccination
Intramuscular vaccination is expected to be the growing route of administration. The majority of vaccines are administered through this intramuscular route. Delivery through this route decreases severe reactions at the injection site. Intramuscular injections are extensively adopted as they deliver medications deep inside muscle tissues, resulting in quick absorption. Thus, this factor boosts the growth of the market.
- Growing Production Capacity
Several manufacturers are increasing their production capacity. The increasing demand for packaging materials is estimated to rise as production capacity increases. For instance, in February 2021, AstraZeneca entered into a partnership with IDT Biologika to develop a new manufacturing plant in Germany. IDT Biologika is a German C.R.O. that also manufactures and fills glass vials. The rate at which the virus grows into a more infectious strain is anticipated to increase vaccine demand. Thus, this factor increases the market growth.
Restraints/Challenges
- Side-Effects of Vaccine Administration Devices
There are various side effects associated with vaccine administration devices that impede market growth. Effects such as redness and soreness at the injection site or fever and allergic reactions. Furthermore, needle-free injections have huge drawbacks with clinical concerns. The high-pressure delivery of drugs can damage fragile molecules beneath the skin layer, particularly in the administration of monoclonal antibodies. All these factors hamper the growth of the market.
This vaccine administration devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the vaccine administration devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In 2020, BD. (Becton, Dickinson, and Company) and the US government entered into a partnership agreement for the reduction of TB in Indonesia. As the US government highlights more on the vaccination program, this partnership assisted the company in providing its advanced vaccine delivery syringes on a huge scale which led the company to earn more benefits.
- In 2019, Gerresheimer AG launched a new US glass innovation and technology center. The company is engaged in manufacturing glass syringes and needles for vaccine administration. This expansion assisted the company in improving the production of various vaccine administration devices.
Asia-Pacific Vaccine Administration Devices Market Scope
The vaccine administration devices market is segmented on the basis of product, route of administration, type, brand, dosage, vaccine type, modality, usability, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Syringes
- Auto Injectors
- Jet Injectors
- Micro Needles
- Inhalation/Pulmonary Delivery
- Microinjection System
- Pen Injector Devices
- Biodegradable Implants
- Electroporation-Based Needle Free Injection Systems
- Buccal /Sublingual Vaccine Delivery Systems
- Auto-Injector Trainer Devices
- Others Devices
Route of Administration
- Intramuscular
- Subcutaneous
- Intradermal
Type
- Marketed Vaccines
- Clinical-Stage Vaccines (Electroporation)
Brand
- BD Accuspray Nasal Spray System
- BD Hypak for Vaccines Glass Pre-Fillable Syringe System
- BD Uniject Auto-Disable Pre-Fillable Injection System
- Gx InnoSafe
- Gx RTF ClearJect, Plajex
- Others
Dosage
- Fixed
- Variable
Vaccine Type
- Bivalent Oral PolioVaccine
- BCG Vaccine
- Tetanus-Diphtheria Vaccine
- DTP-HEPB-HIB Vaccine
- Influenza Vaccine
- Pneumococcal Conjugate Vaccine
- Measles Vaccine
- Others
Modality
- Automatic Vaccine Administration Device
- Manual Vaccine Administration Device
Usability
- Disposable
- Reusable
End User
- Hospitals
- Community Centers
- Homecare Setting
- Research and Academic Institutes
- Ambulatory Surgical Center
- Others
Distribution Channel
- Direct Tender
- Retail Sales
Vaccine Administration Devices Market Regional Analysis/Insights
The vaccine administration devices market is analyzed and market size insights and trends are provided by product, route of administration, type, brand, dosage, vaccine type, modality, usability, end user, and distribution channel as referenced above.
The major countries covered in the vaccine administration devices market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
Japan is anticipated to grow with the highest CAGR in the forecast period due to increase in consumer demand and advanced healthcare infrastructure in the country. Also, several governments globally are growing their spending on vaccination and demonstrating strong and effective leadership and ownership of immunization programs in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Asia-Pacific Vaccine administration devices Market Share Analysis
The vaccine administration devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to vaccine administration devices market
Key players operating in the vaccine administration devices market include:
- Medtronic (Ireland)
- Stening S.R.L. (Argentina)
- Cook (U.S.)
- Bicakcilar Medical (Istanbul)
- TROGE MEDICAL GmbH (Germany)
- Henan Tuoren Medical Device Co., Ltd. (China)
- Fisher & Paykel Healthcare Limited (new Zealand)
- Medis Medical (UK.) Ltd (UK.)
- Pulmodyne, Inc. (US.)
- Fuji Systems (Japan)
- DEAS SRL (Italy)
- Sterimed Group (India)
- ConvaTec Group PLC (U.K.)
- Smiths Medical (UK.)
- Andreas Fahl Medizintechnik – Vertrieb GmbH (Germany)
- Boston Medical Products Inc. (US.)
- TRACOE medical GmbH (Germany)
- Teleflex Incorporated (US.)
- Well Lead Medical Co., Ltd (China)
SKU-